ERBB3 and cancer: In 65% of patients (41 of 63), cancer tissues showed an overexpression of EGFR compared with normal tissues, whereas 79 and 81% (50 of 63 and 51 of 63, respectively) of patients showed an overexpression of cytoplasmic Her-2 and ErbB3, respectively (Supplementary Table 2).